Q1 2026 Management View “In Q1, we completed the installation of the Eagle Line and commenced start-up operations. We are producing initial volumes of QSE-5 cells,” said (President, CEO & Director ...

Beggs stated, "Our full year guidance reflects a balance between encouraging demand trends across our portfolio and continued macro uncertainty and volatility." She set full year 2026 guidance for ...

Parsons reported $6.4 billion in revenue for fiscal year 2025, while achieving record adjusted EBITDA and net income for the full year. How Did Parsons Perform Financially in Fiscal Year 2025? In an ...

Preliminary bookings in the quarter were estimated at approximately $257 million, bringing orders for the full year to approximately $924 million. The Company also maintained its preliminary revenue ...

Note: Figures in historical dollars (excluding IAS29) are included for comparison purposes. This announcement includes certain references to Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted EBITDA ...

Transaction closed and fully funded for the $41 million acquisition, with no additional public equity raising required for the transactionCompany ...

“I am incredibly proud of our team in delivering another outstanding quarterly result,” said John Wyskiel, President & CEO of Blue Bird Corporation. “The Blue Bird team continued to exceed ...

LAVAL, Québec, March 04, 2026 (GLOBE NEWSWIRE) -- Savaria Corporation (SIS:CA), one of the global leaders in the accessibility industry, is pleased to announce its results for fiscal 2025. Highlights ...

For full year 2026, McNeely announced, "We are excited to announce our 2026 adjusted EBITDA guidance of $205 million to $225 million which represents over 20% year-over-year growth at the midpoint." ...

Surgery Partners reported AN Adjusted EBITDA decline of 4.2% in Q4 following projections for continued expanding margins -- Levi & Korsinsky, LLP investigates potential securities law violations Last ...